Results 111 to 120 of about 47,632 (221)

Atypical presentation of visceral leishmaniasis from non-endemic region [PDF]

open access: yes, 2010
A case of atypical and acute presentation of visceral leishmaniasis from non-endemic region, characterised by exudative pleural effusion and hepatitis is ...
Gupta, D, Kashyap, R, Kaul, R, Raina, S
core   +1 more source

An Overview of theLaboratory Diagnostic Procedures of Visceral Leishmaniasis (Kala-Azar)

open access: yesMedical Laboratory Journal, 2013
Visceral leishmaniasis (Kala-azar) is a systemic infection disease that can be diagnosed by some invasive procedures such as splenic, liver biopsy or bone marrow aspiration, whichare determined as the gold standards for diagnosing of this disease.
M Fakhar, E Ahmad Pour
doaj  

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis [PDF]

open access: yes
Previous studies demonstrated safety, immunogenicity and efficacy of DNA/modified vaccinia virus Ankara (MVA) prime/boost vaccines expressing tryparedoxin peroxidase (TRYP) and Leishmania homologue of the mammalian receptor for activated C kinase (LACK ...
Alcami, Antonio   +7 more
core   +1 more source

The epidemiology of Leishmania donovani infection in high transmission foci in India.

open access: yes, 2010
OBJECTIVE: Visceral Leishmaniasis (VL) is highly prevalent in Bihar, India. India and its neighbours aim at eliminating VL, but several knowledge gaps in the epidemiology of VL may hamper that effort.
Andersen, Elisabeth W   +10 more
core   +1 more source

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy.

open access: yes, 2007
Leishmaniasis is a geographically widespread severe disease, with an increasing incidence of two million cases per year and 350 million people from 88 countries at risk. The causative agents are species of Leishmania, a protozoan flagellate.
Ayala, Francisco J   +15 more
core   +2 more sources

Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis. [PDF]

open access: yesRev Panam Salud Publica, 2022
Ibiapina AB   +6 more
europepmc   +1 more source

[Visceral leishmaniasis].

open access: yesPrzeglad epidemiologiczny, 2003
Leishmanioses are widespread in 88 countries of the tropical and subtropical zone, including regions of the Mediterranean Sea basin of Southern Europe. Actually, approximately 350 million of people live in Leishmania endemic areas and about 12 million of individuals are infected.
Jerzy, Stefaniak   +3 more
openaire   +1 more source

Immunity and immunosuppression in experimental visceral leishmaniasis

open access: yesBrazilian Journal of Medical and Biological Research, 2004
Leishmaniasis is a disease caused by protozoa of the genus Leishmania, and visceral leishmaniasis is a form in which the inner organs are affected. Since knowledge about immunity in experimental visceral leishmaniasis is poor, we present here a review on
Goto H., Lindoso J.A.L.
doaj  

A Leishmania infantum FML-ELISA for the Detection of Symptomatic and Asymptomatic Canine Visceral Leishmaniasis in an Endemic Area of Iran [PDF]

open access: yes
Background: Visceral leishmaniasis (VL) is caused by Leishmania infantum in Mediterranean basin and is an endemic disease in some parts of Iran. Canines are the main reservoirs of VL in most of the endemic areas.
بهلولی, شهاب   +6 more
core  

Home - About - Disclaimer - Privacy